Skip to main content
. Author manuscript; available in PMC: 2016 Dec 2.
Published in final edited form as: Genet Med. 2016 Apr 28;18(12):1258–1268. doi: 10.1038/gim.2016.40

Table 2. Semi-quantitative metric to score clinical actionability.

Domain Scores
Severity: What is the nature of the threat to health to an individual carrying a clearly deleterious allele in this gene? 3 = Reasonable possibility of sudden death
2 = Reasonable possibility of death or major morbidity
1 = Modest morbidity
0 = Minimal or no morbidity
Likelihood of disease: What is the chance that a serious outcome will materialize given a deleterious variant (akin to penetrance)? 3 = >40% chance
2 = 5–39% chance
1 = 1–4% chance
0 = <1% chance
Effectiveness of specific interventions: How effective is the selected, specific intervention for preventing or significantly diminishing the risk of harm? 3 = Highly effective
2 = Moderately effective
1 = Minimally effective
0 = Controversial or unknown effectiveness
IN = Ineffective/No interventiona
Nature of intervention: How risky, medically burdensome, or intensive is a given intervention? 3 = Low risk, or medically acceptable and low-intensity interventions
2 = Moderate risk, moderately acceptable or intensive interventions
1 = Greater risk, less acceptable and substantial interventions
0 = High risk, poorly acceptable or intensive interventions
State of the knowledge base: What is the level of evidence? A = Substantial evidence, or evidence from a high tier (Tier 1)
B = Moderate evidence, or evidence from a moderate tier (Tier 2)
C = Minimal evidence, or evidence from a lower tier (Tier 3 or 4)
D = Poor evidence, or evidence not provided in the report
E = Evidence based on expert contributions (Tier 5)
a

Do not score the remaining categories.